Jack Turner
Deputy Director, Medicines Access Policy, Medicines Value and Access, NHS England
Jack Turner is the Deputy Director for Medicines Access, NHS England. He is responsible for leading NHS England’s market access policy team, working cross-functionally to conceptualise, develop, and execute frameworks that ensure value for patients, taxpayers, and the pharmaceutical sector. A key part of his role is ensuring good interconnectivity between regulatory, HTA and reimbursement processes and Jack represents NHS England on the management board for ILAP.
Prior to this, Jack was Deputy Director of EU and International Policy at the MHRA, where he headed up Brexit strategy and EU negotiations for the organisation and developed an international strategy–determining how partnerships with other country regulators could be used to deliver on the MHRA’s long-term priorities.
Jack has previously held roles in the life-sciences sector, consulting and the broader NHS, with a focus on care pathway design, public private partnerships and novel payment models for pharmaceuticals.